Active LitigationMDL 3181
Spinal Cord Stimulator Lawsuit Facts
TorHoerman Law is actively accepting claims for the Spinal Cord Stimulator Lawsuit.
Active Litigation·MDL 3181
TorHoerman Law is actively accepting claims for the Spinal Cord Stimulator Lawsuit.
Spinal cord stimulators may need to be removed when a device malfunctions, migrates, causes infection, delivers painful stimulation, or no longer provides meaningful pain relief.
Removal can involve additional risks, including bleeding, cerebrospinal fluid leaks, retained lead fragments, nerve injury, worsening pain, and other neurological complications.
TorHoerman Law is reviewing claims from patients who suffered serious injuries after spinal cord stimulator failure, revision surgery, or device removal.

Spinal cord stimulators are used to manage chronic back pain, failed back surgery syndrome, nerve pain, and other conditions that have not responded to more conservative treatment.
Although some patients experience meaningful pain relief, complications involving an implanted stimulator can lead to revision surgery or complete device removal.
Lead migration is a common complication and may cause the device to stop providing effective stimulation, send electrical impulses to nearby nerves, or create new areas of pain.
Other problems may involve infection, hardware failure, painful shocks, burns, chest pain, worsening neurological symptoms, or complications involving rechargeable implantable pulse generators.
Removing a spinal cord stimulator can create additional risks, particularly when permanent leads are surrounded by scar tissue or positioned near the spinal cord and other sensitive structures.
Possible removal complications include bleeding, hematoma, cerebrospinal fluid leaks, retained lead fragments, nerve injury, worsening pain, weakness, loss of sensation, and other neurological problems.
Some patients require additional hospitalization, corrective procedures, or long-term treatment after complications develop during or after spinal cord stimulator removal.
A spinal cord stimulator removal claim may require an investigation into why the device was removed, whether the stimulator or its components failed, whether adequate warnings were provided, and whether the removal procedure caused additional injury.
TorHoerman Law can review implant records, explant reports, imaging, device information, medical records, and other evidence to determine whether a defective spinal cord stimulator or another preventable problem may have contributed to the patient’s injuries.
If you or a loved one suffered serious complications during or after spinal cord stimulator removal, you may be able to file a claim and seek compensation.
Contact TorHoerman Law today for a free consultation, or use the chat feature on this page to find out whether you may qualify for a spinal cord stimulator lawsuit.
Complication rates after spinal cord stimulator removal vary depending on the type of lead being removed, whether other spinal surgery is performed at the same time, the amount of scar tissue surrounding the device, and the patient’s surgical history.
Published studies have reported different complication rates depending on the type and complexity of the removal procedure:
These findings show why there is not one complication rate that applies to every spinal cord stimulator removal.
Standalone electrode removal may carry a relatively low complication rate, while paddle lead removal can be more complex because scar tissue may form around the electrode near the spinal cord and dura.

Potential complications of removal can include infection, bleeding, hematoma, cerebrospinal fluid leaks, wound complications, retained lead fragments, worsening pain, and neurological injury.
Complications associated with the original spinal cord stimulator implantation are generally more common than complications from removal alone.
Research has reported:
Lead migration, infection, device failure, and other implantation complications can eventually result in revision surgery or complete removal of the spinal cord stimulator.
Patients who undergo repeated procedures or more complex paddle lead removal may face additional surgical risks because of scar tissue and changes to the tissue surrounding the spinal cord.
Spinal cord stimulators may be removed when they no longer provide meaningful pain relief, develop hardware problems, cause infection, or create new symptoms that outweigh the benefits of continued spinal cord stimulation.
Loss of pain relief is one of the most common reasons for removal.
A 2025 systematic review of spinal cord stimulator explantation found that lack of efficacy or inadequate pain relief accounted for approximately 38% of explantations studied.
Patients generally undergo a trial period before permanent implantation, and a successful trial typically requires at least a 50% reduction in pain.
However, successful short-term stimulation does not guarantee that an implanted device will continue controlling chronic pain or failed back surgery syndrome over the long term.
Pain relief may decline as the patient’s underlying condition changes, the body adjusts to stimulation, leads move from their intended position, or the device develops mechanical or electrical problems.
Lead migration can interfere with the electrical impulses intended to modify pain signals near the spinal cord and nearby nerves.
Although anchoring techniques are used to reduce lead movement, migration can still require reprogramming, lead revision, or complete removal.

Common reasons why a spinal cord stimulator may be removed include:
A healthcare provider may first attempt reprogramming, medication changes, or other measures when the problem can be corrected without additional surgery.
Hardware problems may sometimes be addressed through revision rather than complete explantation.
However, serious infection, persistent device failure, neurological complications, or continued loss of therapeutic benefit may make complete spinal cord stimulator removal necessary.
Spinal cord stimulator removal is a surgical procedure used to remove part or all of an implanted spinal cord stimulation system.
The procedure generally involves removing the implantable pulse generator and the leads that carry electrical stimulation to the epidural space near the spinal cord.
Anchors, connecting wires, scar tissue, or infected or damaged tissue may also need to be addressed during spinal cord stimulator explantation.
How the device is removed depends largely on whether the spinal cord stimulator implant uses percutaneous leads or paddle leads.

The procedure may also vary based on where the generator is located, how the leads were anchored during SCS implantation, and whether the device has been implanted for a few weeks or several years.
Percutaneous lead removal is generally less involved than paddle lead removal.
Paddle leads are larger, may be anchored beneath part of the spinal column, and can become surrounded by scar tissue over time.
Spinal cord stimulator removal may be performed under general anesthesia, although the anesthesia plan depends on the type of leads, the complexity of the procedure, and the patient’s medical condition.
Patients should discuss with their healthcare provider which components will be removed and what complications may occur during or after surgery.
A permanent spinal cord stimulator system generally includes an implantable pulse generator, one or more leads containing electrodes, and connecting components.
The pulse generator is commonly positioned beneath the skin in the buttock or lower back, while the leads extend toward the spinal cord and deliver stimulation from within the epidural space.
During removal, the surgeon typically makes an incision over the generator pocket, disconnects the pulse generator from the leads, and removes the generator.
A separate incision may be required near the spine to locate and remove the implanted leads.

The process differs depending on the type of lead:
According to Johns Hopkins, removal of percutaneous leads generally takes about an hour, while paddle lead removal may take approximately two and a half hours and is typically performed under general anesthesia.
Paddle leads can make spinal cord stimulator explantation more involved because they are larger and are commonly placed through a surgical opening near the spinal column rather than through an epidural needle.
After SCS implantation, the body forms scar tissue around implanted components.
With paddle leads, this scar tissue can form a capsule around the electrode near the spinal cord and dura.
During removal, the surgeon may need to open this scar capsule and carefully separate the paddle lead from the surrounding tissue.
In some cases, a small amount of bone may also need to be removed to access the lead.
Working near the dura and other structures of the nervous system creates risks that are less prominent during routine removal of temporary leads.

Potential complications can include:
Percutaneous leads are usually easier to remove, but complications may still arise if a lead has migrated, fractured, become embedded in scar tissue, or cannot be removed intact.
The complexity of removal therefore depends not only on how long the spinal cord stimulator implant has been in place, but also on the type of lead, prior revision procedures, scar tissue formation, and the location of the implanted components.
Spinal cord stimulator explantation is generally considered a low-risk procedure, but complications can occur during surgery or while the patient is recovering.
The risks depend partly on the type of lead being removed, the amount of scar tissue surrounding the device, prior spinal procedures, and whether additional surgery is performed at the same time.

Potential complications after spinal cord stimulator removal may include:
Nerve damage or other neurological injury may occur when spinal cord stimulator leads and surrounding scar tissue are manipulated during removal.
Paddle lead explantation can be particularly complex because scar tissue may form near the dura and spinal cord, requiring careful dissection to remove the implanted electrode.
A cerebrospinal fluid leak can occur if the dura is unintentionally opened during lead removal. Some CSF leaks can be managed without another operation, but more serious or persistent leaks may require secondary repair surgery.
Other risk factors may include previous infection, repeated revision procedures, extensive scar tissue, lead type and location, anticoagulant use, smoking, diabetes, and other conditions that can affect bleeding or wound healing.
Most patients do not experience major complications after spinal cord stimulator removal.
However, new weakness, severe or rapidly worsening pain, fever, wound drainage, severe headache, loss of sensation, or loss of bladder or bowel control after surgery should receive prompt medical evaluation.
A complication after spinal cord stimulator removal does not automatically mean that a product liability claim exists.
A lawsuit may warrant investigation when evidence suggests that a defective spinal cord stimulator, inadequate warning, or device malfunction contributed to the need for removal or caused additional harm.
For example, a patient may have required explant surgery after lead migration, hardware failure, painful stimulation, battery problems, device malfunction, infection associated with the device, or another problem involving the spinal cord stimulation system.
Product liability claims may focus on whether the device had a design defect, manufacturing defect, or inadequate warnings about known risks.

Depending on the circumstances, a spinal cord stimulator removal lawsuit may involve:
An attorney may review implant and explant reports, imaging, device model and serial information, manufacturer warnings, recall or safety information, adverse event reports, and the timeline between implantation, device problems, revision procedures, and removal to determine whether the evidence supports a product liability claim.
Spinal cord stimulator lawsuits are being filed by patients who allege that implanted devices caused serious injuries, malfunctioned, or failed to provide the pain relief they were intended to deliver.
During a spinal cord stimulator trial, temporary leads are generally connected to an external generator before a patient proceeds to permanent implantation.
Some systems are designed to create a tingling sensation that replaces or masks pain signals, while newer stimulation methods may operate without noticeable paresthesia.
Patients involved in current lawsuits allege that spinal cord stimulators caused them to feel pain, electrical shocks, burning sensations, new or worsening nerve symptoms, loss of stimulation, or other complications.
Claims may involve lead migration or fracture, battery and charging problems, defective components, unintended stimulation, or problems involving rechargeable systems.

Manufacturers named in spinal cord stimulator product liability litigation include:
Plaintiffs generally allege that manufacturers sold defective spinal cord stimulation systems or failed to adequately warn patients and physicians about known risks.
These allegations remain subject to litigation, and the facts and legal theories can differ depending on the manufacturer and device involved.
Some patients undergo repeated reprogramming or revision procedures before the spinal cord stimulator is ultimately removed.
In those cases, explantation may become important evidence of the severity and progression of the alleged device problem, particularly when lead migration, hardware failure, painful stimulation, infection, or loss of therapeutic benefit led to additional surgery.
Federal lawsuits involving Boston Scientific spinal cord stimulators were centralized in June 2026 in MDL No. 3181 in the Central District of California.
The U.S. Judicial Panel on Multidistrict Litigation declined at that time to create one industry-wide proceeding covering devices made by Abbott, Nevro, Medtronic, and other manufacturers, meaning claims involving different manufacturers may proceed separately as the litigation develops.
TorHoerman Law is investigating spinal cord stimulator product liability claims involving serious injuries, device failures, revision procedures, and explant surgery.
Evidence is important because spinal cord stimulator removal claims often involve complicated medical and device issues.
A claim may require proof that the implanted device, the removal surgery, a manufacturer’s conduct, or a medical provider’s conduct caused serious harm.

Important evidence may include:
This evidence can help determine whether the spinal cord stimulator malfunctioned, whether known risks were adequately disclosed, and how the device-related complications affected the patient.
Compensation for spinal cord stimulator removal complications may depend on the severity of the injury, the cost of medical treatment, the number of additional surgeries, and the impact on the patient’s daily life.
A patient who suffers permanent nerve damage, paralysis, or repeated corrective surgeries may have different damages than a patient who experiences temporary surgical pain.

Potential compensation may include:
No attorney can guarantee compensation.
A lawyer can review the patient’s medical records, device information, removal timeline, and damages to determine what losses may be available in a claim.
Spinal cord stimulator injuries can involve device failure, lead migration, painful stimulation, neurological symptoms, infection, revision surgery, or complete device removal.
TorHoerman Law is reviewing product liability claims involving spinal cord stimulation systems manufactured by companies including Boston Scientific, Abbott, Nevro, and Medtronic.
An attorney can review medical records, device information, implant and explant reports, adverse event data, and manufacturer warnings to identify factors that may have contributed to the injury.
These cases may require a detailed investigation into whether the spinal cord stimulator was defectively designed or manufactured, whether the device malfunctioned, or whether patients and physicians received adequate warnings about known risks.

If you or a loved one suffered serious complications involving a spinal cord stimulator, TorHoerman Law can review your case and explain whether you may qualify to file a product liability claim.
Contact TorHoerman Law for a free consultation.
You can also use the chat feature on this page to find out if you may qualify for a spinal cord stimulator removal complications lawsuit.
A spinal cord stimulator may be removed when the device no longer provides adequate pain relief, develops hardware problems, causes infection, or creates new symptoms that outweigh its benefits.
A 2025 systematic review found that inadequate pain relief or lack of efficacy accounted for approximately 38% of explantations, followed by lead failure and infection.
Other reasons an SCS device may need to be removed include:
Loss of pain relief can occur even when the patient initially had a successful trial and was satisfied with the device.
Yes.
Scar tissue can form around implanted leads, particularly paddle leads that have remained near the spinal cord for an extended period.
During removal, the surgeon may need to separate the lead from this scar tissue while avoiding the spinal cord, dura, and nearby spinal nerves.
Manipulating these structures can increase the complexity of the procedure and may create risks such as dural puncture, cerebrospinal fluid leakage, bleeding, or neurological injury.
Paddle leads are generally more involved to remove than percutaneous leads because they are larger and may be positioned beneath part of the spinal column.
Most patients do not experience serious complications after spinal cord stimulator removal, but problems can occur during surgery or recovery.
Potential complications include:
Johns Hopkins reports that complications occur in approximately 2% to 3% of removal procedures and identifies infection and cerebrospinal fluid leakage as recognized risks.
A CSF leak may sometimes require another procedure to repair the dura.
Yes.
A spinal cord stimulator does not cure the underlying condition causing chronic pain, so removal eliminates the electrical stimulation the device was providing.
Patients whose devices were still providing some benefit may experience increased pain or a return toward their previous pain levels after removal.
Patients whose devices were removed because they had already stopped working may have experienced significant pain before explantation.
After removal, a healthcare provider may discuss other approaches to pain management, which can include:
Explantation rates vary based on the device, patient population, reason for implantation, length of follow-up, and how researchers define device failure.
A 2025 systematic review of 13,026 patients found that 9.82% underwent spinal cord stimulator explantation, with inadequate pain relief being the most common reason.
Long-term research using survival analysis has found that the cumulative risk of explantation increases as patients are followed for longer periods.
One study reported explantation rates of approximately 17% at three years, 23% at five years, and 38% at ten years.
Research also shows that pain reduction and patient satisfaction do not always measure the same outcome.
Some patients report satisfaction with SCS treatment even when their measured reduction in pain is below 50%.
Complication rates vary significantly across studies because researchers evaluate different SCS devices, implantation methods, follow-up periods, and patient populations.
A 2026 systematic review and meta-analysis of 33 studies found that 24% of patients experienced at least one adverse event, while 3% experienced at least one serious adverse event.
Lead migration occurred more frequently than infection.
Earlier research published in Pain Practice and associated with the World Institute of Pain reviewed 707 spinal cord stimulation cases and reported hardware-related complications in 38%, including lead migration, connection failure, and lead breakage.
That study also documented infection and pain around the implanted generator.
These studies evaluate complications associated with spinal cord stimulation generally and should not be interpreted as complication rates specifically for removal surgery.
Removal may become relevant to a product liability claim when evidence suggests that a defective spinal cord stimulator or inadequate warning contributed to serious injuries or made revision or explant surgery necessary.
Potential claims may involve:
The fact that an SCS device was removed does not by itself establish that the product was defective.
An attorney may review implant and explant records, device identification information, imaging, manufacturer warnings, adverse event reports, and the history of device problems to determine whether the evidence supports a product liability claim.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Spinal Cord Stimulator Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.